Breaking Finance News

Mazor Robotics Ltd – ADR (NASDAQ:MZOR) target price raised to $25.00, reported today by B. Riley

Yesterday Mazor Robotics Ltd – ADR (NASDAQ:MZOR) traded -2.82% lower at $25.89. The company’s 50-day moving average is $23.33 and its 200-day moving average is $18.19. The last stock close price is up 38.33% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 202,802 shares of the stock were exchanged, up from an average trading volume of 162,235

Mazor Robotics Ltd – ADR (NASDAQ:MZOR) had its target price raised to $25.00 by B. Riley in a report released 10/11/2016. The new target price indicates a possible downside of -0.03% based on the company's last stock close price.

Previously on 10/07/2016, B. Riley reported about Mazor Robotics Ltd – ADR (NASDAQ:MZOR) raised the target price from $0.00 to $25.00. At the time, this indicated a possible upside of 0.13%.

See Chart Below

Mazor Robotics Ltd - ADR (NASDAQ:MZOR)

Mazor Robotics Ltd – ADR has a 52 week low of $8.31 and a 52 week high of $26.55 The company’s market cap is currently $0.

In addition to B. Riley reporting its target price, a total of 5 firms have reported on the stock. The consensus target price is $17.10 with 2 firms rating the stock a strong buy, 2 firms rating the stock a buy, 2 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.

About Mazor Robotics Ltd – ADR (NASDAQ:MZOR)

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications. Its Renaissance System and its predecessor are used in a number of spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision and cement augmentations. Furthermore the Company developed the Renaissance Brain Module, an application of its Renaissance System that provides control over the insertion of surgical instruments during brain surgery.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *